Five-year Pan-European, longitudinal surveillance of Clostridium difficile ribotype prevalence and antimicrobial resistance: the extended ClosER study

Clostridium difficile infection (CDI) has been primarily treated with metronidazole or vancomycin. High recurrence rates, the emergence of epidemic PCR ribotypes (RTs) and the introduction of fidaxomicin in Europe in 2011 necessitate surveillance of antimicrobial resistance and CDI epidemiology. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Freeman, Jane, Vernon, Jonathan, Pilling, Sally, Morris, Kirsti, Nicolson, Scott, Shearman, Sharie, Clark, Emma, Palacios-Fabrega, Jose Alejandro, Wilcox, Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962284/
https://www.ncbi.nlm.nih.gov/pubmed/31811507
http://dx.doi.org/10.1007/s10096-019-03708-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6962284/
https://www.ncbi.nlm.nih.gov/pubmed/31811507
http://dx.doi.org/10.1007/s10096-019-03708-7

Ejemplares similares